CEPHALON INC
Healthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY10 | FY09 | FY08 | |
|---|---|---|---|
| Revenue | $2.81B | $2.19B | $1.97B |
| Operating income | $717.6M | $334.0M | $184.5M |
| Net income | $425.7M | $342.6M | $193.0M |
| Total assets | $4.89B | $4.66B | — |
| Total liabilities | $2.05B | $1.97B | — |
| Equity | $2.63B | $2.26B | $1.42B |
| EPS (diluted) | $5.27 | $4.41 | $2.54 |
| Shares out. | 75.7M | 74.9M | 76.1M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2010- Operating margin
- 25.5%
- Net margin
- 15.1%
- Return on equity
- 16.2%
- Return on assets
- 8.7%
- Return on capital (ROCE)
- 19.5%
- Liabilities / assets
- 42.0%
- Debt / equity
- 0.78×
- Book value / share
- $34.78
- Revenue growth (YoY)
- 28.2%
- Net income growth (YoY)
- 24.3%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2010- Altman Z″ (distress)
- 3.75safe
- Accruals / assets
- −7.3%clean
- Piotroski F-Score
- 7/9strong
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 1 severe● 7 good- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating margin is positive
- Strong return on equity (>15%)
- Revenue is growing year-over-year
- Conservative leverage (liabilities < 50% of assets)
- Positive operating cash flow
- Clean earnings (low accruals)
- Altman Z″ in the safe zone
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗Aug 10, 2006
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
FDA-approved drugs
openFDA · most recent- TREANDAMar 20, 2008
- FENTORASep 25, 2006
- TRISENOXSep 25, 2000
- ACTIQNov 4, 1998
- GABITRILSep 30, 1997
- FENTANYLOct 4, 1993
Material events
SEC Form 8-K · most recent- Completed an acquisition or disposition · New financial obligation · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Other material eventOct 14, 2011
- Other material eventOct 11, 2011
- Other material eventSep 30, 2011
- Other material eventSep 26, 2011
- Other material eventAug 22, 2011
- Results of operationsAug 2, 2011
- Other material eventJul 21, 2011
- Shareholder vote · Other material eventJul 14, 2011
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SC 13G/AAMENDMENT NO.2 TO SCHEDULE 13GMar 31, 2017
- SC 13G/AAMENDMENT NO.1 TO SCHEDULE 13GMar 10, 2017
- 3FORM 3 SUBMISSIONMar 27, 2015
- SC 13GMar 27, 2015
- SC 13G/AFeb 10, 2012
- SC 13G/AJan 26, 2012
- POSASRDec 21, 2011
- S-8 POSDec 21, 2011
- S-8 POSDec 21, 2011
- S-8 POSDec 21, 2011
- S-8 POSDec 21, 2011
- S-8 POSDec 21, 2011
- S-8 POSDec 21, 2011
- SC 13DNov 14, 2011
- 15-12GOct 19, 2011
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.